Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy | MicrobiomeTrials← Back to trialsNCT02262806
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2014-10-14Est. Completion: 2027-07-31
Enrollment target: 29 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Diet TherapyHealthy Volunteers
Background:
Diet is one of the most modifiable behaviors affecting health. But diet assessment measures that are based …
Phoenix, United StatesEst. completion Jan 1, 2028
T2DM (Type 2 Diabetes Mellitus)
The goal of this clinical trial is to evaluate whether an evidence-based anti-inflammatory dietary intervention can redu…
Hefei, ChinaEst. completion Nov 2026
Recruiting
This study aims to investigate how fat accumulation in the pancreas contributes to the development of type 2 diabetes (T…
Edinburgh, United KingdomEst. completion Mar 30, 2029